Elad Gil
Venture capitalSeed–Growth · 1 people tracked
Investment thesis
Elad Gil runs Gil&Co, a multi-stage investment firm focused on the technology future. He invests across stages and has backed prominent technology and AI companies, often getting involved early in machine learning and generative AI. Beyond investing, he incubates and helps start companies, has founded operating businesses, and pursues interests in longevity and anti-aging biotech, human capital, and large-scale inspirational projects. His track record spans early bets and led rounds in numerous high-profile startups.
Source: firm website, verified Jul 28, 2026.
Team · 1 people
from the firm's websiteTechnology entrepreneur and investor who runs Gil&Co, a multi-stage investment firm. He previously founded Mixerlabs (acquired by Twitter) and Color Health, was a VP at Twitter, worked on AI and mobile at Google, holds a PhD from MIT in Math and Biology, and authored the High Growth Handbook.
What they invest in
from 3 of 39 portfolio companiesAI & Machine Learning ×2Biotech ×2Longevity ×2Enterprise Software ×1Healthtech ×1LegalTech ×1
Investments · 39 tracked
founders shown can be your intro pathBIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases. The company uses data-driven approaches and bioinformatics to identify and develop its pipeline of aging-focused therapeutics.
BiotechHealthtechLongevity
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)
Builds an AI platform for the world's largest institutions
Harvey provides domain-specific AI products for legal and professional services firms, enabling contract analysis, due diligence, compliance, and litigation tasks. The platform is used by law firms and Fortune 500 enterprises globally to improve decision-making efficiency.
AI & Machine LearningEnterprise SoftwareLegalTech
NewLimit develops epigenetic reprogramming medicines to extend healthspan and treat age-related diseases at the intersection of computer science and biotechnology. The company builds therapeutic programs that aim to engineer cell identity and reprogram cell age for human patients.
AI & Machine LearningBiotechLongevity
Jacob(Co-founder, Head of Research, President, and CEO)Brian Armstrong(Co-founder, Board of Directors)
Frequently asked questions
- What stage does Elad Gil invest at?
- Elad Gil invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Elad Gil focus on?
- Elad Gil focuses on AI & Machine Learning, Biotech, Crypto & Web3, Enterprise Software, Fintech, Longevity.
- Does Elad Gil lead rounds?
- Yes, Elad Gil leads investment rounds.
Media · Podcasts & interviews
featuring the teamHow Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview - YouTube
My First Million · Elad Gil
Build 2026 Podcast: Satya Nadella, Sarah Guo and Elad Gil from No Priors, and Swyx from Latent Space - YouTube
Microsoft · Elad Gil
No Priors Ep. 138 | The Best of 2025 (So Far) with Sarah Guo and Elad Gil - YouTube
No Priors: AI, Machine Learning, Tech, & Startups · Elad Gil
How To Navigate Your Career | Elad Gil | Ep. 6 - YouTube
Uncapped with Jack Altman · Elad Gil
No Priors Ep. 86 | With Sarah Guo & Elad Gil - YouTube
No Priors: AI, Machine Learning, Tech, & Startups · Elad Gil
No Priors Ep. 81 | With Sarah Guo & Elad Gil - YouTube
No Priors: AI, Machine Learning, Tech, & Startups · Elad Gil
Images
Similar investors
Alumni Ventures is a venture firm that gives accredited individual investors access to professionally managed venture deals, co-investing alongside leading lead VC firms across stages and geographies. It offers diversified funds, syndicate deal-by-deal access, and various investor clubs.
GV, originally launched as Google Ventures in 2009, is an independent venture capital firm with Alphabet as its sole limited partner. It invests from seed to growth stages across technology and life sciences and supports founders with operating partners and access to Google and Alphabet resources.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
NJF Capital is the venture investment arm of NJF Holdings, a private investment group founded by Nicole Junkermann. It backs transformative technology companies internationally across life sciences, deep tech, fintech, and human performance.
Mammoth (Mammoth Scientific / Mammoth Investors, LLC) is a venture capital firm specializing in health science and technology funds, helping founders scale their products, operations, and teams.